about
Candidacidal activities of human lactoferrin peptides derived from the N terminusSynergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida speciesObtaining control of cell surface functionalizations via Pre-targeting and Supramolecular host guest interactionsNew chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.In vivo detection of amyloid-β deposits using heavy chain antibody fragments in a transgenic mouse model for Alzheimer's diseaseRadiolabelled antimicrobial peptides for infection detection.Detection of fungal infections using radiolabeled antifungal agents.The use of technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging.Future diagnostic agents.In vivo biodistribution of stem cells using molecular nuclear medicine imaging.Prosthetic joint infections: radionuclide state-of-the-art imaging.Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence.Development and prospects of dedicated tracers for the molecular imaging of bacterial infections.Development of a Hybrid Tracer for SPECT and Optical Imaging of Bacterial Infections.Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.Performance of a 99mTc-labelled 1-thio-beta-D-glucose 2,3,4,6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG.Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulationEnhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.Potential role of antimicrobial peptides in the early onset of Alzheimer's disease.The many roads to infection imaging.Improved radioiodination of biomolecules using exhaustive Chloramine-T oxidation.Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections.Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis.Various routes of administration of (99m)Tc-labeled synthetic lactoferrin antimicrobial peptide hLF 1-11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice.Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection.Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.Bis-pyridylethenyl benzene as novel backbone for amyloid-β binding compounds.Tracers for fluorescence-guided surgery: how elongation of the polymethine chain in cyanine dyes alters the pharmacokinetics of a (bimodal) c[RGDyK] tracer.First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery.Tailoring Fluorescent Dyes To Optimize a Hybrid RGD-Tracer.Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands.A Supramolecular Approach for Liver Radioembolization.Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivoErratum to: First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgeryEx vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse modelSynthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in miceDetection of experimental infections with 99mTc-labeled monoclonal antibodies against TNF-α and interleukin-8Contribution of phagocytic cells and bacteria to the accumulation of technetium-99m labelled polyclonal human immunoglobulin at sites of inflammationOptimized localization of bacterial infections with technetium-99m labelled human immunoglobulin after protein charge selection
P50
Q24290527-C8056089-59C3-46CB-9AFC-ED13DD57ACEEQ24549843-ABF86B9B-5EBD-47F5-BA44-40708B381978Q28817957-24C69BAF-4681-4D49-B5CB-390D03B7A658Q31091099-54691E38-86CB-4B07-9867-8044D9B387F3Q34295798-92B1222C-6661-4FCB-BCBC-C644F7C78F23Q35101147-CA833BB4-BFE7-44D1-8AA1-A52966DA695DQ36352182-401584FC-7EBE-4F4B-BAD5-47229BE451C5Q37265071-0F0CFA02-E26F-4F76-BFE2-F5A55D52C486Q37336242-BB8F6338-1FC1-435D-8F8D-FA05B30814E2Q37853947-F21E7498-2A49-425D-BDCF-6FE90B9BABC8Q37987812-9B11EC21-582F-4843-90AE-130C87453DADQ38106898-2FB5E7B4-B2F2-4887-96C0-CC1DE68D9E6FQ38160587-86109EDF-D899-4F45-A8C2-C224E9666FECQ38889813-936CA1BB-0285-4ED7-8FAF-FC90EE764B11Q39518711-628E3813-2D36-49EA-BA1E-DAC5526EF214Q39759436-BD8B56F5-188E-43FB-A822-7263C8E11BB0Q39810189-43D2A381-918E-4837-9DB7-935B02C313D2Q41454171-458B69E4-64C8-41BE-A6F3-91761D2EC971Q42230906-08784D4B-2819-4753-AE75-07659D423A9CQ43146250-AAFB781B-F4B7-4308-BF1E-8E11E79ADBE5Q43801223-5563D426-9CBC-4093-830D-6FA135BDE45FQ44408373-6705251E-BD50-43B7-9BA2-9B0C85E8F04BQ45120168-1031B5B2-F40D-4959-A229-0BB4C3758004Q46635504-3500EAFE-309A-4BEA-9F28-3FBAB07C91D5Q46961472-C4534E5F-3D81-4309-8D88-1E1BE65C1F69Q47743799-34167CD4-02F7-4ECA-B6C5-DC2C1EED655AQ48184464-D0C1BA44-A51A-4687-93D9-77E58D52C8BAQ48432254-C8E25DEA-184F-4E6E-AA4B-843345A940B4Q49959892-F374BCE3-D775-4C55-B768-C2015F7E8671Q50264860-4ED8D674-8CA7-4B4F-955A-F89C71D13192Q52983664-EDAD28B7-B2BF-45FF-A405-F4CCEC308017Q53350617-CE99D9E7-5816-4C2E-A628-6FB918439D11Q55128492-F1C649B6-297B-4918-A73F-0B5C786E89E6Q58234954-55D02326-9F5F-4EC4-A3EE-25FEF343B8F2Q59192665-F97C10D7-21A6-4734-97B4-D36781BD5D38Q59192681-9EF9EFD9-29D4-4BC2-A4CF-3920AA65392DQ59192682-0133A6B4-A541-485A-B462-3005D74CCAC9Q59192710-AFE3B703-C157-4959-9063-EB6E3D141283Q59192712-D916A6F9-7911-4051-A91C-C4D97CE5B4EBQ59192714-C3AA8114-8A37-4884-AFAE-89755BA6A6D7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mick M Welling
@ast
Mick M Welling
@en
Mick M Welling
@es
Mick M Welling
@nl
type
label
Mick M Welling
@ast
Mick M Welling
@en
Mick M Welling
@es
Mick M Welling
@nl
prefLabel
Mick M Welling
@ast
Mick M Welling
@en
Mick M Welling
@es
Mick M Welling
@nl
P106
P1153
7004935135
P31
P496
0000-0002-2249-5601